Cargando…
Induction of Expression of p75 Neurotrophin Receptor Intracellular Domain Does Not Induce Expression or Enhance Activity of Mitochondrial Complex II
Fenretinide is a chemotherapeutic agent in clinical trials for the treatment of neuroblastoma, among the most common and most deadly cancers of childhood. Fenretinide induces apoptosis in neuroblastoma cells through accumulation of mitochondrial reactive oxygen species released from Complex II. The...
Autores principales: | Yang, Yaoli Pu, Lotta, Louis, Beutner, Gisela, Li, Xingguo, Schor, Nina F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657150/ https://www.ncbi.nlm.nih.gov/pubmed/26640617 http://dx.doi.org/10.1155/2016/8752821 |
Ejemplares similares
-
Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells
por: Yang, Yaoli Pu, et al.
Publicado: (2016) -
Cerebellar Purkinje cell p75 neurotrophin receptor and autistic behavior
por: Lotta, L T, et al.
Publicado: (2014) -
Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor
por: Zhang, Tong, et al.
Publicado: (2009) -
Expression and purification of the p75 neurotrophin receptor transmembrane domain using a ketosteroid isomerase tag
por: Li, Qingxin, et al.
Publicado: (2012) -
Structural basis of death domain signaling in the p75 neurotrophin receptor
por: Lin, Zhi, et al.
Publicado: (2015)